Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub, our library of evidence-based guidance on GLP-1 therapies, weight-management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education
An independent editorial review. PlexusDx holds no commercial relationship with Hers or its parent company, and this page contains no affiliate links or paid placement.
Hers is one of several telehealth brands operating in the GLP-1 and weight-management category. The pages below map the landscape a shopper is really choosing among, how these programs are built, and the one variable that separates them from a genetics-first approach. Fair-balance framing, not a purchase recommendation. Current as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Where Hers sits in the GLP-1 telehealth field
Hers is the women-focused arm of Hims & Hers Health, a publicly traded direct-to-consumer telehealth company. In the weight-management category it functions as a subscription service: a licensed provider reviews your case remotely, and, if you qualify, a prescription is routed to a pharmacy for fulfillment. Anyone weighing alternatives is really comparing variations on that same skeleton rather than fundamentally different medicine. The brand's current program structure and pricing live on Hers's official website.
What separates one program from the next
Across the category, the differences that matter are narrow. Programs diverge on who signs the prescription (a physician versus a nurse practitioner or physician assistant), which pharmacy fills it (a retail pharmacy dispensing FDA-approved brand products, or a 503A compounding pharmacy preparing compounded semaglutide or tirzepatide), and how the subscription is packaged and billed. Everything else, the intake questionnaire, the clinician review, the titration follow-up, tends to look similar from brand to brand.
The compounds every alternative is built on
Whichever brand you choose, the pharmacology comes from the same short list. GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide, are the molecules doing the work. Their evidence base is public: the STEP program studied semaglutide for weight management (The New England Journal of Medicine, 2021), SURMOUNT studied tirzepatide for weight management (NEJM, 2022), and SURMOUNT-OSA examined tirzepatide in obstructive sleep apnea (NEJM, 2024). Trial populations and endpoints differ, and individual outcomes vary.
Pricing across the alternatives
Published pricing for Hers appears on the brand's own site, and comparable programs post their own. Totals move with the product chosen, the subscription tier, and whether a program dispenses brand or compounded medication. Across the telehealth GLP-1 market as of April 2026, monthly totals typically land between roughly $200 and $700+, with wide variance. Confirm any current number at Hers's official website before committing, because these figures change often.
The genetic layer the alternatives skip
Comparing brands answers the wrong question if none of them look at your genetics. Telehealth programs like this one do not examine the upstream genetic architecture that shapes every GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the direct target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the baseline metabolic terrain any compound acts on. These are pathway-level markers. They do not predict response to a specific medication, but they describe the biology a clinician is prescribing into, context a prescription alone never captures.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is that upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Reading that profile alongside the protocol is the test before you invest approach, turning guesswork into an informed conversation with your healthcare provider.
Not affiliated: PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.
Disclaimer: This article is educational. PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Weigh the PlexusDx approach against the alternatives: see the Weight Management Protocols, semaglutide and tirzepatide paired with the genetic context most telehealth programs omit. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions About Hers Alternatives
What are the main alternatives to Hers for GLP-1 support?
The category is crowded with subscription telehealth brands that share the same skeleton: remote clinical review, a written prescription, and pharmacy fulfillment. They differ mostly in provider type, pharmacy partner, and pricing tier. PlexusDx differs more fundamentally by pairing its protocols with upstream genetic testing.
How do compounded and brand-name GLP-1 options differ?
Brand-name products are FDA-approved and dispensed by retail pharmacies, while compounded semaglutide or tirzepatide is prepared by 503A compounding pharmacies for individual patients. Availability, cost, and formulation differ between the two pathways, so verify which a program uses before choosing among alternatives.
Where does PlexusDx fit among the alternatives?
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols and adds the Precision Peptide Genetic Test for pathway-level context. The differentiator is genetic insight into FTO, MC4R, and TCF7L2, which most telehealth-only alternatives do not provide alongside the medication.
Does switching programs change the underlying biology?
No. Moving from one telehealth brand to another changes the service, not your metabolism. The genetic variants that shape baseline GLP-1, appetite, and energy-balance biology stay the same regardless of which program writes the prescription, which is why upstream testing applies across every alternative.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Hers Pricing: Why Discount Codes Don't Change What You Pay
Henry Meds Weight Loss Program: Medications and Pricing